Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Abbar

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Translational Lung Cancer Research|September 15, 2025
A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategiesLu Zhou, Takehiro Uemura, Baptiste Abbar, et al.
Bulletin Du Cancer|January 26, 2020
[HIV and cancer: Update 2020]Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor TreatmentPaul Gougis, Baptiste Abbar, Julie Benzimra, et al.
Head & Neck|March 11, 2025
Prognosis and Phenotypes of Advanced Head and Neck Carcinoma Associated With HypercalcemiaElodie Mamou, Paul Gougis, Baptiste Abbar, et al.
Translational Lung Cancer Research|November 14, 2025
Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective studyCoraline Cheuvart, Paul Gougis, Luca Campedel, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Journal of Thoracic Disease|April 14, 2025
Development and validation of multi-sequence magnetic resonance imaging radiomics models for predicting tumor response to radiotherapy in locally advanced non-small cell lung cancerShangqun Liu, Yan Lv, Liwen Duan, et al.
Translational Lung Cancer Research|January 20, 2025
Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective studyCamille Santonja, Paul Gougis, Elise Dumas, et al.
AIDS (London, England)|October 22, 2019
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?Baptiste Abbar, Marine Baron, Christine Katlama, et al.
Translational Lung Cancer Research|June 19, 2025
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysisLiang Liu, Wen Bao, Xiaoshuai Yuan, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Translational Lung Cancer Research|September 15, 2025
A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategiesLu Zhou, Takehiro Uemura, Baptiste Abbar, et al.
Bulletin Du Cancer|January 26, 2020
[HIV and cancer: Update 2020]Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor TreatmentPaul Gougis, Baptiste Abbar, Julie Benzimra, et al.
Head & Neck|March 11, 2025
Prognosis and Phenotypes of Advanced Head and Neck Carcinoma Associated With HypercalcemiaElodie Mamou, Paul Gougis, Baptiste Abbar, et al.
Translational Lung Cancer Research|November 14, 2025
Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective studyCoraline Cheuvart, Paul Gougis, Luca Campedel, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Journal of Thoracic Disease|April 14, 2025
Development and validation of multi-sequence magnetic resonance imaging radiomics models for predicting tumor response to radiotherapy in locally advanced non-small cell lung cancerShangqun Liu, Yan Lv, Liwen Duan, et al.
Translational Lung Cancer Research|January 20, 2025
Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective studyCamille Santonja, Paul Gougis, Elise Dumas, et al.
AIDS (London, England)|October 22, 2019
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?Baptiste Abbar, Marine Baron, Christine Katlama, et al.
Translational Lung Cancer Research|June 19, 2025
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysisLiang Liu, Wen Bao, Xiaoshuai Yuan, et al.
Pageof 4